Alport syndrome news

December 3, 2018December 3, 2018

Newly Identified DDR1 I Inhibitor Can Prevent Kidney Fibrosis, Loss of Function in Alport Syndrome Mice

Inhibition of the DDR1 enzyme with a newly identified small molecule compound can prevent renal tissue scarring and renal function loss in a mouse model of Alport syndrome, a study ... Read more

October 6, 2017

Alport Syndrome Case Study to Be Presented at AAO Annual Meeting

Alport syndrome news, News

A case study of Alport syndrome will be the subject of an oral presentation and discussion at the 96th annual meeting of the American Academy of Optometry (AAO), Oct. 11-14 ... Read more

June 12, 2017

Regulus Back on Track with RG-012 Clinical Development for Alport Syndrome

Alport syndrome news, News

Regulus Therapeutics has completed dosing of its Alport syndrome drug candidate RG-012 in a Phase 1 trial testing several ascending doses of the treatment in healthy volunteers. The treatment was ... Read more

June 9, 2017June 9, 2017

Alport Syndrome Foundation’s Virtual Walk Kicks Off June 17

Alport syndrome news, News

The Alport Syndrome Foundation (ASF) welcomes all who are interested to take part in its 2nd Annual Virtual Walk, a fundraising event to help fight Alport syndrome. Virtual walk participants can walk anytime, anywhere, and ... Read more